Eribulin mesylate induces bone mass loss by promoting osteoclastic bone resorption in mice.
Ishizaka T, Horiuchi K, Kondo S, Isaji M, Nakagawa T, Inoue M, Rikitake H, Taguchi E, Susa M, Yoda M, Ono T, Kozai Y, Chiba K.
Ishizaka T, et al. Among authors: horiuchi k.
Bone Rep. 2023 May 30;18:101693. doi: 10.1016/j.bonr.2023.101693. eCollection 2023 Jun.
Bone Rep. 2023.
PMID: 37305428
Free PMC article.